Glaukos (GKOS)
(Delayed Data from NYSE)
$107.62 USD
+0.71 (0.66%)
Updated May 9, 2024 04:00 PM ET
After-Market: $107.64 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Glaukos Corporation [GKOS]
Reports for Purchase
Showing records 81 - 100 ( 123 total )
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
Healthcare - Coverage Update - Healthcare Sector
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
We are placing shares of GKOS Under Review, and transferring coverage to Scott Henry, CFA due to the departure of the covering analyst.
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Near-Term Transient Headwinds Linger, But Long-Term Thesis Unchanged
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
iStent Inject Standalone Study Publication Unveils Positive Results
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
ASCRS Reinforces MIGS Long-Term Opportunities; Buy
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Solid 2017 Start on 1Q Beat, 2017 Guidance Raise
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Making Glaucoma Great Again - Management Travels Reaffirm Bullish Outlook
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.